These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 34635148
21. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV. Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500 [Abstract] [Full Text] [Related]
22. Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia. Turki A, Stockler S, Sirrs S, Salvarinova R, Ho G, Branov J, Rosen-Heath A, Bosdet T, Elango R. Mol Genet Metab Rep; 2022 Jun; 31():100880. PubMed ID: 35585965 [Abstract] [Full Text] [Related]
23. Glomerular and tubular function in glycogen storage disease. Lee PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV. Pediatr Nephrol; 1995 Dec; 9(6):705-10. PubMed ID: 8747109 [Abstract] [Full Text] [Related]
24. Liver transplantation for type I and type IV glycogen storage disease. Selby R, Starzl TE, Yunis E, Todo S, Tzakis AG, Brown BI, Kendall RS. Eur J Pediatr; 1993 Dec; 152 Suppl 1(Suppl 1):S71-6. PubMed ID: 8319729 [Abstract] [Full Text] [Related]
25. Kidney Function After Liver Transplantation in a Single Center. Niewiński G, Smyk W, Graczyńska A, Kostrzewa K, Raszeja-Wyszomirska J, Ołdakowska-Jedynak U, Małyszko J, Wójcicki M, Zieniewicz K. Ann Transplant; 2021 Feb 23; 26():e926928. PubMed ID: 33619240 [Abstract] [Full Text] [Related]
26. Longterm Outcomes of Living Donor Liver Transplantation for Glycogen Storage Disease Type 1b. Shimizu S, Sakamoto S, Horikawa R, Fukuda A, Uchida H, Takeda M, Yanagi Y, Irie R, Yoshioka T, Kasahara M. Liver Transpl; 2020 Jan 23; 26(1):57-67. PubMed ID: 31587472 [Abstract] [Full Text] [Related]
27. [Advances on the management of renal lesion in glycogen storage disease type I]. Wu WC, Wang JS. Zhonghua Gan Zang Bing Za Zhi; 2021 Jan 20; 29(1):75-78. PubMed ID: 33541027 [Abstract] [Full Text] [Related]
28. Glycemic management in living donor liver transplantation for patients with glycogen storage disease type 1b. Karaki C, Kasahara M, Sakamoto S, Shigeta T, Uchida H, Kanazawa H, Kakiuchi T, Fukuda A, Nakazawa A, Horikawa R, Suzuki Y. Pediatr Transplant; 2012 Aug 20; 16(5):465-70. PubMed ID: 22574785 [Abstract] [Full Text] [Related]
29. Clinical features of gout in adult patients with type Ia glycogen storage disease: a single-centre retrospective study and a review of literature. Xu N, Han X, Zhang Y, Huang X, Zhu W, Shen M, Zhang W, Jialin C, Wei M, Qiu Z, Zeng X. Arthritis Res Ther; 2022 Feb 26; 24(1):58. PubMed ID: 35219330 [Abstract] [Full Text] [Related]
30. Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review. Dahlberg KR, Ferrecchia IA, Dambska-Williams M, Resler TE, Ross KM, Butler GL, Kuo CL, Ryan PT, Weinstein DA. J Inherit Metab Dis; 2020 Mar 26; 43(2):269-278. PubMed ID: 31415093 [Abstract] [Full Text] [Related]
31. Peri-operative risk factors of chronic kidney disease after liver transplantation. Chopinet S, Bobot M, Reydellet L, Bollon E, Gérolami R, Decoster C, Blasco V, Moal V, Grégoire E, Hardwigsen J. J Nephrol; 2022 Mar 26; 35(2):607-617. PubMed ID: 34426948 [Abstract] [Full Text] [Related]
32. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring. Halaby CA, Young SP, Austin S, Stefanescu E, Bali D, Clinton LK, Smith B, Pendyal S, Upadia J, Schooler GR, Mavis AM, Kishnani PS. Genet Med; 2019 Dec 26; 21(12):2686-2694. PubMed ID: 31263214 [Abstract] [Full Text] [Related]
33. Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. Chen YT. Pediatr Nephrol; 1991 Jan 26; 5(1):71-6. PubMed ID: 2025544 [Abstract] [Full Text] [Related]
34. Does the pediatric end-stage liver disease score or hepatic artery resistance index predict outcome after liver transplantation for biliary atresia? Asthana S, McClean P, Stringer MD. Pediatr Surg Int; 2006 Sep 26; 22(9):697-700. PubMed ID: 16896815 [Abstract] [Full Text] [Related]
35. Hepatocyte transplantation for glycogen storage disease type Ib. Lee KW, Lee JH, Shin SW, Kim SJ, Joh JW, Lee DH, Kim JW, Park HY, Lee SY, Lee HH, Park JW, Kim SY, Yoon HH, Jung DH, Choe YH, Lee SK. Cell Transplant; 2007 Sep 26; 16(6):629-37. PubMed ID: 17912954 [Abstract] [Full Text] [Related]
36. Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy. Okechuku GO, Shoemaker LR, Dambska M, Brown LM, Mathew J, Weinstein DA. J Inherit Metab Dis; 2017 Sep 26; 40(5):703-708. PubMed ID: 28612263 [Abstract] [Full Text] [Related]
37. Echocardiographic Assessment of Patients with Glycogen Storage Disease in a Single Center. Seol J, Jung S, Koh H, Jung J, Kang Y. Int J Environ Res Public Health; 2023 Jan 25; 20(3):. PubMed ID: 36767559 [Abstract] [Full Text] [Related]
38. One-Year Follow-up of the Changes in Renal Function After Liver Transplantation in Patients Without Chronic Kidney Disease. Kang GW, Lee IH, Ahn KS, Kim JD, Kwak SG, Choi DL. Transplant Proc; 2016 May 25; 48(4):1190-3. PubMed ID: 27320584 [Abstract] [Full Text] [Related]
39. Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Reddy SK, Kishnani PS, Sullivan JA, Koeberl DD, Desai DM, Skinner MA, Rice HE, Clary BM. J Hepatol; 2007 Nov 25; 47(5):658-63. PubMed ID: 17637480 [Abstract] [Full Text] [Related]
40. The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI. Grünert SC, Hannibal L, Spiekerkoetter U. Genes (Basel); 2021 Aug 03; 12(8):. PubMed ID: 34440378 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]